213 related articles for article (PubMed ID: 36708807)
21. The effects of RNA editing in cancer tissue at different stages in carcinogenesis.
Kurkowiak M; Arcimowicz Ł; Chruściel E; Urban-Wójciuk Z; Papak I; Keegan L; O'Connell M; Kowalski J; Hupp T; Marek-Trzonkowska N
RNA Biol; 2021 Nov; 18(11):1524-1539. PubMed ID: 33593231
[TBL] [Abstract][Full Text] [Related]
22. lncRNAfunc: a knowledgebase of lncRNA function in human cancer.
Yang M; Lu H; Liu J; Wu S; Kim P; Zhou X
Nucleic Acids Res; 2022 Jan; 50(D1):D1295-D1306. PubMed ID: 34791419
[TBL] [Abstract][Full Text] [Related]
23. RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis.
Song Y; An O; Ren X; Chan THM; Tay DJT; Tang SJ; Han J; Hong H; Ng VHE; Ke X; Shen H; Pitcheshwar P; Lin JS; Leong KW; Molias FB; Yang H; Kappei D; Chen L
J Hepatol; 2021 Jan; 74(1):135-147. PubMed ID: 32693003
[TBL] [Abstract][Full Text] [Related]
24. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
25. ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion.
Cesarini V; Silvestris DA; Tassinari V; Tomaselli S; Alon S; Eisenberg E; Locatelli F; Gallo A
Nucleic Acids Res; 2018 Feb; 46(4):2045-2059. PubMed ID: 29267965
[TBL] [Abstract][Full Text] [Related]
26. Adenosine-to-Inosine Editing of MicroRNA-487b Alters Target Gene Selection After Ischemia and Promotes Neovascularization.
van der Kwast RVCT; van Ingen E; Parma L; Peters HAB; Quax PHA; Nossent AY
Circ Res; 2018 Feb; 122(3):444-456. PubMed ID: 29284691
[TBL] [Abstract][Full Text] [Related]
27. Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets.
Pinto Y; Buchumenski I; Levanon EY; Eisenberg E
Nucleic Acids Res; 2018 Jan; 46(1):71-82. PubMed ID: 29165639
[TBL] [Abstract][Full Text] [Related]
28. Genomic Landscape and Potential Regulation of RNA Editing in Drug Resistance.
Zhou X; Mitra R; Hou F; Zhou S; Wang L; Jiang W
Adv Sci (Weinh); 2023 May; 10(14):e2207357. PubMed ID: 36912579
[TBL] [Abstract][Full Text] [Related]
29. Large-scale prediction of ADAR-mediated effective human A-to-I RNA editing.
Yao L; Wang H; Song Y; Dai Z; Yu H; Yin M; Wang D; Yang X; Wang J; Wang T; Cao N; Zhu J; Shen X; Song G; Zhao Y
Brief Bioinform; 2019 Jan; 20(1):102-109. PubMed ID: 28968662
[TBL] [Abstract][Full Text] [Related]
30. A-to-I RNA editing of BLCAP promotes cell proliferation by losing the inhibitory of Rb1 in colorectal cancer.
Han F; Hu M; Zhang L; Fan X; Wang J; Lou Z; Wang S; Chen L; Ye Y; Ding Y; Jiao H
Exp Cell Res; 2022 Aug; 417(2):113209. PubMed ID: 35605649
[TBL] [Abstract][Full Text] [Related]
31. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target.
Jafarzadeh A; Paknahad MH; Nemati M; Jafarzadeh S; Mahjoubin-Tehran M; Rajabi A; Shojaie L; Mirzaei H
Biomed Pharmacother; 2022 Feb; 146():112600. PubMed ID: 34968919
[TBL] [Abstract][Full Text] [Related]
32. All I's on the RADAR: role of ADAR in gene regulation.
Shevchenko G; Morris KV
FEBS Lett; 2018 Sep; 592(17):2860-2873. PubMed ID: 29770436
[TBL] [Abstract][Full Text] [Related]
33. Hypothesis: RNA editing of microRNA target sites in humans?
Liang H; Landweber LF
RNA; 2007 Apr; 13(4):463-7. PubMed ID: 17255198
[TBL] [Abstract][Full Text] [Related]
34. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
Ramírez-Moya J; Baker AR; Slack FJ; Santisteban P
Oncogene; 2020 Apr; 39(18):3738-3753. PubMed ID: 32157211
[TBL] [Abstract][Full Text] [Related]
35. LNCediting: a database for functional effects of RNA editing in lncRNAs.
Gong J; Liu C; Liu W; Xiang Y; Diao L; Guo AY; Han L
Nucleic Acids Res; 2017 Jan; 45(D1):D79-D84. PubMed ID: 27651464
[TBL] [Abstract][Full Text] [Related]
36. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
Yuting K; Ding D; Iizasa H
Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
[TBL] [Abstract][Full Text] [Related]
37. Recent Advances in Adenosine-to-Inosine RNA Editing in Cancer.
Gan WL; Ng L; Ng BYL; Chen L
Cancer Treat Res; 2023; 190():143-179. PubMed ID: 38113001
[TBL] [Abstract][Full Text] [Related]
38. Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer.
Lee SH; Kim HP; Kang JK; Song SH; Han SW; Kim TY
Cancer Res Treat; 2017 Oct; 49(4):1077-1087. PubMed ID: 28161934
[TBL] [Abstract][Full Text] [Related]
39. A-to-I RNA editing and cancer: from pathology to basic science.
Gallo A; Galardi S
RNA Biol; 2008; 5(3):135-9. PubMed ID: 18758244
[TBL] [Abstract][Full Text] [Related]
40. A-to-I RNA editing as a tuner of noncoding RNAs in cancer.
Liao Y; Jung SH; Kim T
Cancer Lett; 2020 Dec; 494():88-93. PubMed ID: 32822814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
